Tablets & Capsules

TC0319

Issue link: https://www.e-digitaleditions.com/i/1087673

Contents of this Issue

Navigation

Page 23 of 51

22 March 2019 Tablets & Capsules I n the pharmaceutical industry's competitive and ever-changing business climate, companies are fre- quently divesting certain assets and acquiring others. As a result, the industry is often very busy with manufactur- ing site changes and drug product technology transfers. Technology transfer is also part of the manufacturing life cycle for drug products that companies outsource to contract manufacturing organizations (CMOs). However, while pharma companies systematically follow protocols and issue reports for drug product method transfer or validation, they often fail to take the time to issue a plan and report for technology transfer. Technology transfer is very common in pharmaceutical manu- facturing but is often taken for granted, which can lead to pro- duction problems and increased costs. This article describes the documentation steps required for performing a successful solid oral dosage technology transfer. Planning for successful technology transfer Anthony Grenier technology transfer

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - TC0319